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Abstract
Formation and development of the veterinary pharmacy and veterinary drugs market in Ukraine is an urgent issue. In order 
to prevent infection of the mammary gland in cows after milking, the nipples are treated with a suitable disinfectant for complete 
immersion or spraying. However, the agents for the prevention of mastitis, presented in the Ukrainian market, are expensive and 
there is a need to develop domestic veterinary preparations of different forms of release.
This work is a continuation of research on the development of the composition and technology of a means for antiseptic 
treatment of nipples and udders of cattle, in the form of a spray, in order to prevent microbial contamination and prevent mastitis.
To obtain a stable veterinary drug based on citrate of silver and copper, the dissolution regimes of the substances were 
investigated, the order of introduction of the active ingredients and auxiliary substances into the solution, the duration and 
the rate of stirring during dissolution. It is established that the most optimal are the following technological modes of spray 
preparation: dissolution temperature 20–22 oС, mixing time from 10 to 15 minutes, with stirring intensity from 150–200 sec-1. 
The selected technological regime ensures the stability of the veterinary drug “Argocide-copper” during storage for 12 months. 
The technology of obtaining a spray in the conditions of industrial production of veterinary preparations of LLC “Brovafarm” 
(Brovary, Ukraine) is developed. Critical stages and critical control points in the production process of a veterinary preparation 
of antiseptic action are determined.
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1. Introduction
An important task of modern pharmaceutical technology is the creation of effective and 
safe medicines, including veterinary pharmacy. Formation and development of the veterinary 
pharmacy and veterinary drugs market in Ukraine is an urgent issue, which is connected with 
modern processes in society [1]. The problem of mastitis in productive animals is urgent. The 
content of cattle on a limited area of farms leads to an increase in microbial contamination and 
an increase in the virulent properties of the opportunistic bacterial flora. High milk production 
causes the intense functioning of the mammary gland, accompanied by a decrease in organ 
resistance, resulting in inflammation [2]. Therefore, growth the importance of veterinary and 
sanitary measures, especially the prevention and treatment of breast diseases of cattle [3]. 
At the current stage of livestock development, there is no one agro-industrial economy of 
Ukraine that would have bypassed the problem of mastitis cattle. Mastitis causes considerable 
economic damage for all countries of the world. The main costs include a decrease in the dairy 
productivity of animals [4].
In the treatment of mastitis in cows, antibiotic solutions for parenteral administration 
and suspension in syringe tubes for intracisternal use are most often used [5]. Modern an-
ti-mastics are also produced by pharmaceutical factories in the form of gels, ointments, emul-
sions, suspensions and solutions for external use, etc. [6]. According to the State Veterinary 
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and Phytosanitary Service of Ukraine, as of 2017, 46 trade names for cattle mastitis products 
were registered on the veterinary drugs market of the country [7]. But, experience shows that 
the problem of improving dairy herds from mastitis is not always solved by medical measures, 
they must be supported by a set of organizational, economic, zootechnical, veterinary and 
sanitary measures aimed at increasing the nonspecific resistance of the organism, timely elim-
ination of causes and factors contributing to the emergence of new cases disease [8].
In order to prevent infection of the mammary gland in cows after milking, the nipples are 
treated with a suitable disinfectant for complete immersion or spraying. For antiseptic treatment 
of the udder are used agents containing various antiseptic or disinfecting compounds, such as 
chlorhexidine, hydrogen peroxide, bleach, quinazole, phenol and its derivatives [9, 10]. Iodine com-
pounds have become very popular in the prophylactic preparations for the treatment of cattle’s ud-
der [11, 12]. Disadvantages of such drugs may be low effectiveness of treatment, and the possibility 
of causing side effects.
It is established that the drugs for the prevention of mastitis, presented in the Ukrainian mar-
ket, are costly and there is a need to develop domestic veterinary preparations of different forms 
of release [13].
This work is a continuation of the research on the development of the composition and tech-
nology of a means for antiseptic treatment of the nipples and udder of cattle in the form of a spray 
under the conventional name “Argocide-copper”, with the aim of preventing microbial contamina-
tion and preventing mastitis [14, 15].
2. Aim of the research
Substantiation of the technology of obtaining an antimicrobial spray based on silver and 
copper citrate in industrial conditions, determination of critical stages and critical control points in 
the production process.
3. Materials and methods 
As a research object were chosen a series of preparations with the following proportions of 
the components of mass %: silver citrate 15.0–30.0; copper citrate 15.0–30.0; dexpanthenol 0.5–5; 
polyquaternium 10 0.1–1.0; polysorbate 20 0.2–3.0; essential oil of lemon 0,01–2,0; essential oil of 
juniper 0.01–2.0; water purified to 100.0. The active substances – silver and copper citrate, manu-
factured by Nanomaterials and Nanotechnologies Ltd., Kyiv, Ukraine, D – panthenol USP (BASF 
SE, Germany) were used.
The quantitative content of silver ions in the spray was determined by thiocyanometry [16]. 
The quantitative content of copper ions was determined according to the method of the State Phar-
macopoeia of Ukraine 2.0 (SPhU) “2.2.25 Absorption spectrophotometry in the ultraviolet and 
visible regions”. Quantitative determination of dexpanthenol was carried out by liquid chroma-
tography according to the procedure of SPhU “2.2.29. Liquid chromatography. Potentiometric de-
termination of the pH of the experimental samples was carried out according to the procedure of 
SPhU 2.0, item 2.2.3. The measurements were carried out using a pH meter “Seven Easy pH” 
complete with electrodes manufactured by Mettler Toledo (China). The dissolution criterion was 
the absence of “visible particles” in the solution. Statistical processing of experimental data was 
carried out in accordance with the requirements of the article SPhU 2.0 “5.3.N.1. Statistical analysis 
of the results of a chemical experiment” [17].
4. Results
To obtain a stable veterinary drug in the form of a silver citrate and copper spray for veter-
inary medicine, the dissolution regimes of the substances, the order of administration of the active 
ingredients and auxiliary substances into the solution, the duration and rate of stirring during 
dissolution were investigated [18]. The order of administration of ingredients is one of the most 
important factors for obtaining a stable dosage form for veterinary medicine.
The calculated volume of the silver citrate and copper citrate solution was loaded into the 
reactor and purified water was added from the collection tank at a temperature of (20±5) °С, then 
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the reactor was loaded sequentially with stirring: dexpanthenol, stirred for 10–15 minutes; polyqua-
ternium – 10, mixed for 15–20 minutes. Lemon and juniper oil were mixed in a separate container 
with a calculated amount of polysorbate 20, and then added to the stock solution, mixing until 
completely dissolved.
At the same time, technological parameters were processed, including the temperature and 
time regimes, the duration and speed of mixing during the preparation of the solution. Since the 
stability of the solution of citrate of silver and copper depends on the temperature, and the solution 
of silver citrate is not recommended to be heated to a temperature above 500 °C, so the preparation 
of the solution should be carried out at a temperature of 20–22 °С.
We studied the dissolution rate of the components at the chosen temperature regime. Inten-
sity – the speed of achieving the required technological result - the time spent on the distribution 
of the disperse phase in the volume of the continuous phase with the required degree of uniformity. 
The results of the studies are presented in Table. 1.
Table 1
The dissolution rate of the components at the chosen temperature regime
Serial  
number Temperature, 
oС
Number of revolutions of 
stirrer, sec-1
Duration of stirring to  
the absence of insoluble particles in  
solution, min.
1 20–22 50 20–30 
2 20–22 100 15–20
3 20–22 150 10–15
4 20–22 200 10–15
When developing the technology of spray preparation, several preparation regimes were 
studied to obtain a solution that is free from undissolved particles-with different durations and 
mixing speeds. It was found that with a shorter mixing speed, a longer mixing time is required, and 
on the basis of the results obtained, an optimum dissolution time of 10–15 min was chosen which 
was fixed at a stirring speed of 150–200 sec-1.
We also studied the quality indicators of the veterinary drug “Argocide-copper” after 12 
months of storage. The results are shown in Table. 2.
As follows from Table 1, 2, the following technological modes of preparation of an anti-
septic spray are considered to be the most optimal: dissolution temperature 20–22 oC, mixing time 
from 10–15 minutes, with stirring intensity from 150–200 sec-1.
Table 2 shows the quality of the spray after 12 months. storage, which indicates that the 
spray produced by observing the selected optimal values of the dissolution process (temperature 
20–220 °C, duration 10–15 min, stirring speed 150–200, sec-1), retains the values of these indica-
tors within the limits specified in the draft analytical documentation.
It can be argued that the selected technological mode of preparation of the spray based on 
citrate of silver and copper ensures the stability of the veterinary drug “Argocide-copper” during 
storage for 12 months.
The next stage of the research was the development of a technological process for ob-
taining a veterinary drug for external use. Preparation of a solution of an antimicrobial med-
icine based on active silver and copper ions was carried out in a reactor equipped with an 
anchor stirrer. Equipment in which the solution can be exposed to light must be covered. 
50 litres of silver citrate and copper citrate solution were charged to the reactor and 20 litres of 
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purified water at a temperature of (20±5) C were added from the collector, then, sequentially: 
dexpanthenol was added to the reactor with stirring, and stirred for 10–15 minutes; polyqua-
ternium – 10, mixed for 15–20 minutes.
Table 2
Quality indicators of the spray “Argocide-copper” after 12 months of storage.
Serial 
number
Quality indicators according to regulatory documentation
Description 
(unclear liquid of 
a greenish-blue 
color)
Relative 
density,  
g/cm3  
(from 1.016 
to 1.018)
рН 
(2.0–5.0)
Quantitative content, %
Ions of silver 
(not less than 0.0113)
Copper ions (not less 
than 0.0113)
Dexpanthenol  
(4.75–5.25)
1 + 1.016 2.15±0.01 0.0126±0.0002 0.0126±0.0002 5.10±0.01
2 + 1.017 2.13±0.03 0.0125±0.0001 0.0127±0.0001 5.09±0.02
3 + 1.016 2.14±0.03 0.0125±0.0002 0.0125±0.0002 5.09±0.01
4 + 1.016 2.15±0.03 0.0125± 0.0001 0.0125±0.0001 5.08±0.03
Note: + – matches; P±95 %, n=5
Polysorbate 20 was placed in a separate vessel with a stirrer and a stirrer was turned on. 
With the stirrer on, lemon oil and juniper oil were added. Mixing was conducted until a homoge-
neous solution was obtained, at least 15 minutes. Then the contents of the collector, quantitatively 
transferred to a reactor with a solution of silver citrate, copper citrate, dexpanthenol and polyqua-
ternium 10, were mixed until a homogeneous solution was obtained for at least 15 minutes. Then 
the solution volume in the reactor was adjusted to 100.0 L with water and stirred for 10–15 minutes. 
At the end of the preparation process, an average sample was taken to control the intermediate 
product according to the developed analytical normative document for the following parameters: 
pH of the solution; the quantitative content of silver and copper ions, dexpanthenol; appearance. 
The results are shown in Table 3.
After monitoring the intermediate product and obtaining positive results, the solution under 
pressure of inert gas (nitrogen) is transferred to the filters for filtration of the solution with charging 
by the “FILTRAK” filter paper of medium microporosity. It is necessary to control the brand of 
the filter, its integrity, the filtration regime (pressure 0.08–0.10 MPa). The solution after the filter 
enters the collection of the filtered solution. The filtered solution is monitored in terms of: descrip-
tion (hazy liquid of a greenish-blue color), coarse mechanical inclusions (absence), relative density 
(1.016–1.018 g/cm3). The results are shown in Table 4.
When the positive results of the intermediate control were received, the filtered solution 
entered the filling of the vials and their capping. The preparation of the primary packaging was 
carried out in accordance with the company’s document regulating the preparation of primary 
packaging materials.
Filling the vials with a solution and capping the caps of the spray was carried out on an 
automatic line for filling and capping the vials. After filling, the vials with the solution of the 
drug are moved to the capping zone, where the cap of the spray is screwed onto the neck. The in-
termediate product (bottles with solution) was monitored in terms of: the volume of the contents 
of the package (200 ml), the quality of the closure (no leakage of the solution, no deformation 
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of the vial and the spray cap). The sealed bottles are monitored on tables for viewing with the 
naked eye in a darkened room on a black and white background illuminated by a 100W electric 
lamp. Indicators for control: the presence of visible mechanical inclusions, the volume of filling 
(visually), the quality of capping. Vials with mechanical inclusions, incomplete dosage, as well 
as with vial defects and capping are discarded. The vials, which passed control, are given for 
labeling and packaging.
Table 3
The study of the quality indicators of the intermediate product in the preparation of the spray “Argocide-
copper”
Serial 
number
Quality indicators according to regulatory documentation
Appearance 
(unclear liquid of 
a greenish-blue 
color)
pH of  
the solution 
(2.0–5.0)
The quantitative con-
tent, % silver ions  
(not less than 0.0113)
The quantitative 
content, % copper ions 
(not less than 0.0113)
The quantitative con-
tent, % dexpanthenol 
(4.75–5.25)
1 matches 2.17±0.01 0.0127±0.0002 0.0126±0.0002 5.03±0.03
2 matches 2.15±0.02 0.0126±0.0003 0.0127±0.0001 5.01±0.03
3 matches 2.14±0.03 0.0126±0.0003 0.0125±0.0003 5.01±0.03
Note: P±95 %, n=5
Table 4
The study of the quality of the intermediate product (filtered solution) in the preparation of the spray 
“Argocide-copper”
Serial  
number
Quality indicators according to regulatory documentation
Description  
(unclear liquid 
of a greenish- 
blue color)
Relative 
density,  
g/cm3  
(from 1.016 
to 1.018)
рН (2.0–5.0)
Quantitative content, %
Ions of silver (not 
less than 0.0113)
Copper ions (not 
less than 0.0113)
Dexpanthenol 
(4.75–5.25)
1 + 1.017 2.15±0.03 0.0127±0.0002 0.0126±0.0002 5.03±0.03
2 + 1.017 2.14±0.03 0.0126±0.0003 0.0127±0.0001 5.02±0.02
3 + 1.016 2.14±0.03 0.0127±0.0002 0.0125±0.0003 5.01±0.03
Note: + – matches; P±95 %, n=5
Before being sent to the quarantine storage room, the TCD controller selects an average 
sample from the finished product series for a full analysis in accordance with normative analytical 
documentation. Before receiving the results of the analysis, the drug series is located in the quaran-
tine storage room. The scheme of the technological process for the production of a veterinary drug 
is shown in Fig. 1.
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Fig. 1. Block diagram of the technological process of production of the drug “Argocide-copper” 
in the form of a spray: in gray are critical stages and critical control points in the production 
process
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5. Discussion
It should be noted that the production of veterinary drugs in Ukraine in accordance with 
the requirements of good practices is at the implementation stage. The EU Commission adopted 
directives establishing the principles and rules of GMP for medicines and veterinary drugs. Di-
rective 2003/94/EC refers to medicines for humans, and Directive 91/412/EC – medicines for vet-
erinary use [19, 20]. The detailed requirements are in accordance with the principles of Directive 
91/412/EEC set out in the “Guidelines for Basic Rules of Good Practice in the Production and Qual-
ity Control of Veterinary Preparations”, based on which the manufacturers of veterinary drugs in 
Ukraine will be inspected [21].
Medicines for veterinary use are made using materials and methods that ensure microbio-
logical purity, prevent contamination of medicines and the growth of microorganisms. We tested 
the technology of the drug “Argocide-copper” under the conditions of the industrial production 
of veterinary preparations of LLC Brovafarm (Brovary, Ukraine), which allowed to develop and 
standardize it in normative and technological documentation (NTD). NTD consists of the techno-
logical regulations (it includes product data and technological instructions), packing instructions 
and corresponding protocols.
Production of the drug in the form of a spray based on active ions of silver and copper was 
carried out taking into account sanitary and hygienic requirements aimed at preventing microbial 
contamination of raw materials and finished products. For this purpose, the sanitary preparation of 
the production was carried out, which includes the operations of preparation of disinfectant solu-
tions, preparation of ventilation air, production facilities, equipment and inventory, special clothing 
and personnel for work.
The process of production of the drug “Argocide-copper” was carried out in premises with 
a class of purity C, D, which is determined by the content of the maximum permissible mechanical 
particles and microorganisms in the air of the working zone. In the premises of cleanliness class 
C, the preparation, filtration, filling and sealing of the primary packaging, preparation of special 
clothes and personnel were carried out; in the purity class D, primary packaging (bottles, lids) was 
prepared, labeling and packaging of the vials into packs.
6. Conclusions
1. The effects of the preparation regimes and the order of administration of the components 
in the spray under the provisional name “Argocide-copper” on the stability of the preparation based 
on silver citrate and copper for veterinary medicine were studied.
2. It is found that the most optimal are the following technological modes of spray prepara-
tion: dissolution temperature 20–22 °C, mixing time from 10–15 minutes, with stirring intensity 
from 150–200 sec-1. The chosen technological mode11 of preparation of a spray based on citrate of 
silver and copper ensures the stability of the veterinary drug “Argocide-copper” during storage for 
12 months.
3. The technology of obtaining a spray in the conditions of industrial production of veteri-
nary preparations of LLC “Brovafarm” (Brovary, Ukraine) has also been developed. Critical stages 
and critical control points were determined during the production of a veterinary preparation of 
antiseptic action.
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